SHARE YOUR STORY: MDA Educational Events
Have you attended any of the MDA Educational Symposiums? If yes, did you enjoy the experience? What programs, lectures, workshops, etc. would you like to see featured at a future MDA educational event?
Wednesday, August 17, 2011
Thursday, August 4, 2011
SHARE YOUR STORY: Clinical Trials
When diagnosed with a disease not yet curable, patients, caregivers and loved ones are faced with a colossal decision: whether or not to participate in experimental treatments and clinical trials.
http://ping.fm/k8BT9
When diagnosed with a disease not yet curable, patients, caregivers and loved ones are faced with a colossal decision: whether or not to participate in experimental treatments and clinical trials.
http://ping.fm/k8BT9
Tuesday, July 26, 2011
SHARE YOUR STORY: Low Vision
Low vision is a term eye care professionals use to categorize substantial visual impairment that cannot be improved by standard measures, such as regular eyeglasses, contact lenses, medication or even most eye surgeries. As macular degeneration progresses, significant damage occurs in the macula, resulting in low vision.
Do you see a low vision specialist?
If yes, what have you gained from seeking low vision resources?
Low vision is a term eye care professionals use to categorize substantial visual impairment that cannot be improved by standard measures, such as regular eyeglasses, contact lenses, medication or even most eye surgeries. As macular degeneration progresses, significant damage occurs in the macula, resulting in low vision.
Do you see a low vision specialist?
If yes, what have you gained from seeking low vision resources?
Wednesday, July 20, 2011
SHARE YOUR STORY: Vitamins
In 2001, the Age-Related Eye Disease Study (AREDS) research identified a specific formula of antioxidants (vitamin C, vitamin E and beta-carotene) and zinc that reduced the probability of progression to advanced AMD by 25 percent among individuals at risk. Carotenoids, not commercially available at the time of the landmark AREDS study, have since been proven to have even more substantial power in slowing AMD progression.
Do you have a vitamin regimen that you adhere to as a supplemental treatment for slowing AMD progression?
In 2001, the Age-Related Eye Disease Study (AREDS) research identified a specific formula of antioxidants (vitamin C, vitamin E and beta-carotene) and zinc that reduced the probability of progression to advanced AMD by 25 percent among individuals at risk. Carotenoids, not commercially available at the time of the landmark AREDS study, have since been proven to have even more substantial power in slowing AMD progression.
Do you have a vitamin regimen that you adhere to as a supplemental treatment for slowing AMD progression?
Monday, July 11, 2011
CASE STUDY: iPad Grants the Gift of Sight to Legally Blind Woman
Evelyn O’Brien has faced age-related macular degeneration (AMD) for decades. Her AMD progressed to legal blindness over 30 years ago, and for the first time since she lost her vision, she is able to see her grandchildren’s faces…all thanks to Apple’s iPad.
Because of her AMD and resulting legal blindness, when Evelyn looks at people she can't see their faces. She recently discovered that by using her daughter’s iPad she could zoom in and see details she hasn't seen in over 30 years. Evelyn now uses the iPad to read, watch videos, and surf the web.
Evelyn recently brought the iPad into her eye doctor, showed it to him and exclaimed, “Here’s the World!”
http://ping.fm/WHwAp
Evelyn O’Brien has faced age-related macular degeneration (AMD) for decades. Her AMD progressed to legal blindness over 30 years ago, and for the first time since she lost her vision, she is able to see her grandchildren’s faces…all thanks to Apple’s iPad.
Because of her AMD and resulting legal blindness, when Evelyn looks at people she can't see their faces. She recently discovered that by using her daughter’s iPad she could zoom in and see details she hasn't seen in over 30 years. Evelyn now uses the iPad to read, watch videos, and surf the web.
Evelyn recently brought the iPad into her eye doctor, showed it to him and exclaimed, “Here’s the World!”
http://ping.fm/WHwAp
Friday, July 8, 2011
FDA Grants Fast-Track Status to New Treatment for Wet AMD
The U.S. Food and Drug Administration (FDA) recently granted Ohr Pharmaceutical’s Squalamine, a new treatment for wet-AMD, with fast track status and a Special Protocol Assessment (SPA) to speed up progress towards a Phase III clinical trial of the drug.
http://ping.fm/wIc9W
The U.S. Food and Drug Administration (FDA) recently granted Ohr Pharmaceutical’s Squalamine, a new treatment for wet-AMD, with fast track status and a Special Protocol Assessment (SPA) to speed up progress towards a Phase III clinical trial of the drug.
http://ping.fm/wIc9W
Thursday, July 7, 2011
Hopeful Signs for Treating End-Stage AMD Emerge with New Implantable Telescope
According to several studies out of London, England, an implantable telescope shows encouraging results in treating patients with end-stage age-related macular degeneration (AMD).
http://ping.fm/9lYI4
According to several studies out of London, England, an implantable telescope shows encouraging results in treating patients with end-stage age-related macular degeneration (AMD).
http://ping.fm/9lYI4
Subscribe to:
Posts (Atom)